{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:43:25Z","timestamp":1793738605804,"version":"4.6.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,13]],"date-time":"2015-04-13T00:00:00Z","timestamp":1428883200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13048-015-0151-5","type":"journal-article","created":{"date-parts":[[2015,4,12]],"date-time":"2015-04-12T05:04:14Z","timestamp":1428815054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Polycystic ovarian syndrome is accompanied by repression of gene signatures associated with biosynthesis and metabolism of steroids, cholesterol and lipids"],"prefix":"10.1186","volume":"8","author":[{"given":"Dessie","family":"Salilew-Wondim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Schellander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoelker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Munir","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,13]]},"reference":[{"key":"151_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocr Metab. 2004;89:2745\u20139.","journal-title":"J Clin Endocr Metab"},{"key":"151_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/s-2003-43304","volume":"21","author":"RS Legro","year":"2003","unstructured":"Legro RS. Diagnostic criteria in polycystic ovary syndrome. Sem Reprod Med. 2003;21:267\u201375.","journal-title":"Sem Reprod Med"},{"key":"151_CR3","first-page":"671","volume":"30","author":"ME Lujan","year":"2008","unstructured":"Lujan ME, Chizen DR, Pierson RA. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. JOGC. 2008;30:671\u20139.","journal-title":"JOGC"},{"key":"151_CR4","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1210\/jc.2004-0219","volume":"90","author":"RS Legro","year":"2005","unstructured":"Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab. 2005;90:2571\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"151_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/humupd\/dmn015","volume":"14","author":"S Franks","year":"2008","unstructured":"Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008;14:367\u201378.","journal-title":"Hum Reprod Update"},{"key":"151_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456\u201388.","journal-title":"Fertil Steril"},{"key":"151_CR7","doi-asserted-by":"crossref","unstructured":"Goodarzi MO. The genetic basis of the polycystic ovary syndrome. In Androgen excess disorders in women. Springer; 2007. p. 223-33.","DOI":"10.1007\/978-1-59745-179-6_20"},{"key":"151_CR8","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1210\/jc.2013-2375","volume":"98","author":"CK Welt","year":"2013","unstructured":"Welt CK, Carmina E. Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause. J Clin Endocrinol Metab. 2013;98:4629\u201338.","journal-title":"J Clin Endocrinol Metab"},{"key":"151_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/humrep\/des424","volume":"28","author":"L Cui","year":"2013","unstructured":"Cui L, Zhao H, Zhang B, Qu Z, Liu J, Liang X, et al. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum Reprod. 2013;28:538\u201344.","journal-title":"Hum Reprod"},{"key":"151_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s10815-013-0111-1","volume":"30","author":"VR Tumu","year":"2013","unstructured":"Tumu VR, Govatati S, Guruvaiah P, Deenadayal M, Shivaji S, Bhanoori M. An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South Indian women. J Assist Reprod Genet. 2013;30:1541\u20136.","journal-title":"J Assist Reprod Genet"},{"key":"151_CR11","first-page":"497","volume":"36","author":"S Radavelli-Bagatini","year":"2013","unstructured":"Radavelli-Bagatini S, de Oliveira IO, Ramos RB, Santos BR, Wagner MS, Lecke SB, et al. Haplotype TGTG from SNP 45\u00a0T\/G and 276G\/T of the adiponectin gene contributes to risk of polycystic ovary syndrome. J Endocrinol Invest. 2013;36:497\u2013502.","journal-title":"J Endocrinol Invest"},{"key":"151_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1210\/mend.13.6.0311","volume":"13","author":"VL Nelson","year":"1999","unstructured":"Nelson VL, Legro RS, Strauss 3rd JF, McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol. 1999;13:946\u201357.","journal-title":"Mol Endocrinol"},{"key":"151_CR13","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1210\/jc.2008-1231","volume":"93","author":"S Catteau-Jonard","year":"2008","unstructured":"Catteau-Jonard S, Jamin SP, Leclerc A, Gonzales J, Dewailly D, di Clemente N. Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:4456\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"151_CR14","doi-asserted-by":"publisher","first-page":"26380","DOI":"10.1074\/jbc.M300688200","volume":"278","author":"JR Wood","year":"2003","unstructured":"Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, et al. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem. 2003;278:26380\u201390.","journal-title":"J Biol Chem"},{"key":"151_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076460","volume":"8","author":"Y Meng","year":"2013","unstructured":"Meng Y, Qian Y, Gao L, Cai LB, Cui YG, Liu JY. Downregulated expression of peroxiredoxin 4 in granulosa cells from polycystic ovary syndrome. PLoS One. 2013;8, e76460.","journal-title":"PLoS One"},{"key":"151_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mce.2013.01.013","volume":"373","author":"DH Abbott","year":"2013","unstructured":"Abbott DH, Nicol LE, Levine JE, Xu N, Goodarzi MO, Dumesic DA. Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373:21\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"151_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/s-0034-1371090","volume":"32","author":"M Maliqueo","year":"2014","unstructured":"Maliqueo M, Benrick A, Stener-Victorin E. Rodent models of polycystic ovary syndrome: phenotypic presentation, pathophysiology, and the effects of different interventions. Sem Reprod Med. 2014;32:183\u201393.","journal-title":"Sem Reprod Med"},{"key":"151_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2012.10.007","volume":"373","author":"AS McNeilly","year":"2013","unstructured":"McNeilly AS, Duncan WC. Rodent models of polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373:2\u20137.","journal-title":"Mol Cell Endocrinol"},{"key":"151_CR19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.steroids.2013.05.004","volume":"78","author":"V Padmanabhan","year":"2013","unstructured":"Padmanabhan V, Veiga-Lopez A. Animal models of the polycystic ovary syndrome phenotype. Steroids. 2013;78:734\u201340.","journal-title":"Steroids"},{"key":"151_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.fertnstert.2012.04.006","volume":"98","author":"D Shi","year":"2012","unstructured":"Shi D, Vine DF. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Fertil Steril. 2012;98:185\u201393.","journal-title":"Fertil Steril"},{"key":"151_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1095\/biolreprod.111.097808","volume":"86","author":"KA Walters","year":"2012","unstructured":"Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012;86:149. 141-112.","journal-title":"Biol Reprod"},{"key":"151_CR22","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1210\/en.2007-0168","volume":"148","author":"L Manneras","year":"2007","unstructured":"Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M, et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 2007;148:3781\u201391.","journal-title":"Endocrinology"},{"key":"151_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1757-2215-6-36","volume":"6","author":"MM Hossain","year":"2013","unstructured":"Hossain MM, Cao M, Wang Q, Kim JY, Schellander K, Tesfaye D, et al. Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model. J Ovarian Res. 2013;6:36.","journal-title":"J Ovarian Res"},{"key":"151_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1471-2105-9-452","volume":"9","author":"RZ Gharaibeh","year":"2008","unstructured":"Gharaibeh RZ, Fodor AA, Gibas CJ. Background correction using dinucleotide affinities improves the performance of GCRMA. BMC Bioinformatics. 2008;9:452.","journal-title":"BMC Bioinformatics"},{"key":"151_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/0-387-29362-0_23","volume-title":"Bioinformatics and computational biology solutions using R and Bioconductor","author":"GK Smyth","year":"2005","unstructured":"Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and computational biology solutions using R and Bioconductor. New York: Springer; 2005. p. 397\u2013420."},{"key":"151_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Roy Statist Soc Ser B. 1995;57:289\u2013300.","journal-title":"Roy Statist Soc Ser B"},{"key":"151_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/bioinformatics\/btl567","volume":"23","author":"S Falcon","year":"2007","unstructured":"Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics. 2007;23:257\u20138.","journal-title":"Bioinformatics"},{"key":"151_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"BTS Da Wei Huang","year":"2008","unstructured":"Da Wei Huang BTS, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Na Protoc. 2008;4:44\u201357.","journal-title":"Na Protoc"},{"key":"151_CR29","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/bioinformatics\/bti141","volume":"21","author":"G Caraux","year":"2005","unstructured":"Caraux G, Pinloche S. PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics. 2005;21:1280\u20131.","journal-title":"Bioinformatics"},{"key":"151_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1677\/jme.0.0330059","volume":"33","author":"FY Diao","year":"2004","unstructured":"Diao FY, Xu M, Hu Y, Li J, Xu Z, Lin M, et al. The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. J Mol Endocrinol. 2004;33:59\u201372.","journal-title":"J Mol Endocrinol"},{"key":"151_CR31","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1210\/me.2004-0074","volume":"18","author":"E Jansen","year":"2004","unstructured":"Jansen E, Laven JS, Dommerholt HB, Polman J, van Rijt C, van den Hurk C, et al. Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol. 2004;18:3050\u201363.","journal-title":"Mol Endocrinol"},{"key":"151_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0303-7207(86)90128-0","volume":"44","author":"JL Baranao","year":"1986","unstructured":"Baranao JL, Hammond JM. FSH increases the synthesis and stores of cholesterol in porcine granulosa cells. Mo Cel Endocrinol. 1986;44:227\u201336.","journal-title":"Mo Cel Endocrinol"},{"key":"151_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrd1112","volume":"2","author":"JA Tobert","year":"2003","unstructured":"Tobert JA. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov. 2003;2:517\u201326.","journal-title":"Nat Rev Drug Discov"},{"key":"151_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1388-1981(00)00139-6","volume":"1529","author":"LM Olivier","year":"2000","unstructured":"Olivier LM, Krisans SK. Peroxisomal protein targeting and identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes. Biochim Biophys Acta. 2000;1529:89\u2013102.","journal-title":"Biochim Biophys Acta"},{"key":"151_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/toxsci\/kfl051","volume":"94","author":"JT Sanderson","year":"2006","unstructured":"Sanderson JT. The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxico Sci. 2006;94:3\u201321.","journal-title":"Toxico Sci"},{"key":"151_CR36","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1210\/en.2012-1424","volume":"153","author":"Q Wang","year":"2012","unstructured":"Wang Q, Kim JY, Xue K, Liu JY, Leader A, Tsang BK. Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome. Endocrinology. 2012;153:5600\u201311.","journal-title":"Endocrinology"},{"key":"151_CR37","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/sj.ijo.0803730","volume":"31","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E. Role of obesity and adiposity in polycystic ovary syndrome. Int J Obes. 2007;31:S8\u201313.","journal-title":"Int J Obes"},{"key":"151_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/00016348509155113","volume":"64","author":"G Cullberg","year":"1985","unstructured":"Cullberg G, Hamberger L, Mattsson LA, Mobacken H, Samsioe G. Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination. Acta Obstet Gynecol Scand. 1985;64:203\u20137.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"151_CR39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0015-0282(16)48142-2","volume":"42","author":"LA Mattsson","year":"1984","unstructured":"Mattsson LA, Cullberg G, Hamberger L, Samsioe G, Silfverstolpe G. Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertli Steril. 1984;42:579\u201384.","journal-title":"Fertli Steril"},{"key":"151_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-10-153","volume":"10","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Fu L, Li R, Wang LN, Yang Y, Liu NN, et al. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med. 2012;10:153.","journal-title":"BMC Med"},{"key":"151_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1677\/joe.0.1390503","volume":"139","author":"T Tamura","year":"1993","unstructured":"Tamura T, Kitawaki J, Yamamoto T, Osawa Y, Kominami S, Takemorit S, et al. Immunohistochemical localization of 17\u03b1-hydroxylase\/C17-20 lyase and aromatase cytochrome P-450 in polycystic human ovaries. J Endocrinol. 1993;139:503\u20139.","journal-title":"J Endocrinol"},{"key":"151_CR42","unstructured":"Townson DH, Combelles CM. Ovarian follicular atresia. Basic Gynecology\u2013Some Related Issues, Prof. Atef Darwish (Ed.), ISBN: 978-953-51-0166-6, InTech. doi:10.5772\/32465. Available from: http:\/\/www.intechopen.com\/books\/basic-gynecology-some-related-issues\/ovarian-follicular-atresia\/."},{"key":"151_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.anireprosci.2010.08.003","volume":"122","author":"NR Salvetti","year":"2010","unstructured":"Salvetti NR, Stangaferro ML, Palomar MM, Alfaro NS, Rey F, Gimeno EJ, et al. Cell proliferation and survival mechanisms underlying the abnormal persistence of follicular cysts in bovines with cystic ovarian disease induced by ACTH. Anim Reprod Sci. 2010;122:98\u2013110.","journal-title":"Anim Reprod Sci"},{"key":"151_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/rep.0.1240601","volume":"124","author":"AL Durlinger","year":"2002","unstructured":"Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002;124:601\u20139.","journal-title":"Reproduction"},{"key":"151_CR45","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","volume":"140","author":"AL Durlinger","year":"1999","unstructured":"Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology. 1999;140:5789\u201396.","journal-title":"Endocrinology"},{"key":"151_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1600-0897.2010.00917.x","volume":"65","author":"J Shi","year":"2011","unstructured":"Shi J, Yoshino O, Osuga Y, Koga K, Hirota Y, Nose E, et al. Bone morphogenetic protein-2 (BMP-2) increases gene expression of FSH receptor and aromatase and decreases gene expression of LH receptor and StAR in human granulosa cells. Am J Reprod Immunol. 2011;65:421\u20137.","journal-title":"Am J Reprod Immunol"},{"key":"151_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0003-9861(71)90002-6","volume":"145","author":"CT Walsh Jr","year":"1971","unstructured":"Walsh Jr CT, Spector LB. The glucose-glucose 6-phosphate exchange catalyzed by yeast hexokinase. Arch Biochem Biophys. 1971;145:1\u20135.","journal-title":"Arch Biochem Biophys"},{"key":"151_CR48","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0065-2571(01)00061-9","volume":"42","author":"RA Harris","year":"2002","unstructured":"Harris RA, Bowker-Kinley MM, Huang B, Wu P. Regulation of the activity of the pyruvate dehydrogenase complex. Adv Enzyme Regul. 2002;42:249\u201359.","journal-title":"Adv Enzyme Regul"},{"key":"151_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/abbi.2000.2222","volume":"386","author":"S Liu","year":"2001","unstructured":"Liu S, Gong X, Yan X, Peng T, Baker JC, Li L, et al. Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates. ArchBbioche Biophys. 2001;386:123\u201335.","journal-title":"ArchBbioche Biophys"},{"key":"151_CR50","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1210\/jc.2008-1612","volume":"94","author":"JY Kim","year":"2009","unstructured":"Kim JY, Song H, Kim H, Kang HJ, Jun JH, Hong SR, et al. Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94:1416\u201326.","journal-title":"J Clin Endocrinol Metab"},{"key":"151_CR51","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0167-7306(02)36017-4","volume-title":"Biochemistry of lipids, lipoproteins and membranes","author":"L Liscurn","year":"2002","unstructured":"Liscurn L. Cholesterol biosynthesis. In: Biochemistry of lipids, lipoproteins and membranes. 4th ed. New York, N: Elsevier; 2002. p. 409\u201331.","edition":"4"},{"key":"151_CR52","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1016\/j.febslet.2006.07.027","volume":"580","author":"HR Waterham","year":"2006","unstructured":"Waterham HR. Defects of cholesterol biosynthesis. FEBS Lett. 2006;580:5442\u20139.","journal-title":"FEBS Lett"},{"key":"151_CR53","first-page":"2297","volume":"17","author":"ZT Chen","year":"2011","unstructured":"Chen ZT, Wang IJ, Liao YT, Shih YF, Lin LL. Polymorphisms in steroidogenesis genes, sex steroid levels, and high myopia in the Taiwanese population. Mol Vis. 2011;17:2297\u2013310.","journal-title":"Mol Vis"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0151-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-015-0151-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0151-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0151-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T10:30:11Z","timestamp":1717842611000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-015-0151-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,13]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1186\/s13048-015-0151-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,13]]},"assertion":[{"value":"19 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}